Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of ...
Murine double minute 2 (MDM2) mediates the ubiquitination of forkhead box O3 (FOXO3a). hTERT promotes the invasion of gastric cancer via the upregulation of ITGB1. hTERT alleviates the binding of ...
A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat ...